LAU-7b has shown potent antiviral effects against SARS-CoV-2 and MERS-CoV coronaviruses, and is also being developed for its anti-inflammatory properties.
For the treatment of solid tumors expressing a neurotrophic tyrosine receptor kinase (NTRK) gene fusion and ROS1-positive, advanced non-small cell lung cancer.